Velarion Records
Free. Unsubscribe any time.

PLIANT THERAPEUTICS, INC. (PLRX)

PLIANT THERAPEUTICS, INC. filed 9 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 6 reporting owners, covering 10 transactions and 243,571 shares. None carries the SEC's AFF10B5ONE flag; all 9 name a plan in a footnote. No results print is on file in this window, so no interval is measured.

What stands out

Trades in PLIANT THERAPEUTICS, INC. 10

Adoption dates in PLIANT THERAPEUTICS, INC. 1

Results prints in PLIANT THERAPEUTICS, INC. 0

Trades before a print in PLIANT THERAPEUTICS, INC. 0

Interval to PLIANT THERAPEUTICS, INC.’s next reported results date

How the interval and sources are counted →

Adoption dates PLIANT THERAPEUTICS, INC. states

Filing text: “10b5-1 trading plan adopted by the Reporting Person on August 26, 2024”

Sources: SEC EDGAR full-text search and the SEC submissions API.